MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

• By

• Rocío Maseda

• María Carmen Arriba

• Lucía Martínez-Santamaría

• Eva Jiménez

• Sara Herráiz-Gil

• Nuria Illera

• Lucía Quintana-Castanedo

• Marta García

• Susana Suárez-Sancho

• Rosa Yáñez

• Isabel Pérez-Conde

• Marta Carretero

• Magdalena Martínez-Queipo

• Raquel de Paz

• Carlos León

• Víctor Jiménez-Yuste

• Alberto M. Borobia

• Ángeles Vicente

• Su M. Lwin

• John A. McGrath

• María Eugenia Fernández-Santos

• Nora Butta

• Rosa Sacedón

• Marcela del Río

• Raúl de Lucas

• María José Escámez

• May 5, 2026

• 0 min

• Frontiers In Immunology